English
|
Spanish
Supporting oncology professionals through education
Login
Register
The content on this site is intended for healthcare professionals only
Menu
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
News
Latest news
Sign up for news alerts
Submit your news
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Journal information
Journal home
Charges
Editorial board
Founding editors
Editor-in-chief
Contact us
Author information
Submit article
Author guidelines
Editorial policies
Copyright information
Why publish with us
Reviewer information
Reviewer guidelines
Memberships
Videos
Recent videos
Sign up
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Conferences
Latest conferences
Sign up for latest coverage
Submit your event
About
e
cancer
About
e
cancer
Our founders
Funding statement
Contact us
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
+
-
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
Molecular mechanisms of breast cancer tumours
Share :
SABCS 2008
10 - 14 Dec 2008
Please rate this video
The information in this video was of interest to me
The information in this video is likely to improve my clinical practice or research
I would recommend this video to my colleagues
Published:
12 Jan 2009
Views:
16415
Rating:
Save
Rate video
Dr. Kornelia Polyak, Dana-Farber Cancer Institute
Investigating breast cancer tumour evolution and therapeutic resistance
Categories:
Breast
Cell therapy & stem cells
Related Videos
Endocrine therapy plus trastuzumab and pertuzumab shows excellent survival...
Dr Oleg Gluz - Evangeliches Krankenhaus Bethesda Klinik, Mönchengladbach...
14 Sep 2024
Trastuzumab deruxtecan significantly improves PFS In breast cancer patients...
Prof Giuseppe Curigliano - European Institute of Oncology, Milan, Italy
13 Jun 2024
Adjuvant avelumab versus control does not significantly improve DFS but does...
Prof Pier Conte - University of Padova, Padova, Italy
3 Jun 2024
HER2DX assay and survival outcomes: An individual-patient level meta-analysis...
Dr Guillermo Villacampa - Vall d'Hebron Institute of Oncology (VHIO)...
21 May 2024
OncoAlert round up July 28th to August 3rd, 2023
Dr Gil Morgan - Executive Director, OncoAlert
4 Aug 2023
Updates on HR-positive HER2-negative breast cancer
Dr Mariana Chavez - MD Anderson Cancer Center, Houston, USA
8 Jul 2023
ASCO 2023: Highlights and analysis
Assoc Prof Bishal Gyawali - Queen's University, Kingston, Canada
6 Jun 2023
Nine-weeks trastuzumab still effective compared with one year trastuzumab for...
Prof Pierfranco Conte - Istituto Oncologico Veneto, Padova, Italy
3 Jun 2023
Breast cancer in elderly patients: a clinicopathological review of a Nigerian...
Dr Funmilola Wuraola - Obafemi Awolowo University Teaching Hospital, Ilé-Ifẹ̀...
15 Dec 2022
More from
e
cancer